Overview

Gender

female

Kerry Reinertsen, PhD, joined Regeneron in 2011 and currently serves as Senior Vice President of Strategic Alliances. Prior to joining Regeneron, Dr. Reinertsen was Chief Business Officer of Constellation Pharmaceuticals. Before this, Dr. Reinertsen served as the Vice President of Corporate Development at Vertex Pharmaceuticals. Dr. Reinertsen started her biotech career at Millennium Pharmaceuticals (now Takeda Oncology) where she held positions of increasing responsibility in business development. Dr. Reinertsen received her PhD in Biological Chemistry and Molecular Pharmacology from Harvard University and her Sc.B. in Molecular Biology and A.B. in Economics from Brown University.